期刊文献+

卡前列素氨丁三醇在中央性前置胎盘剖宫产时应用时间的探讨及疗效 被引量:29

Evaluation of application time and effects of carboprost trometamol for patient with complete placenta praevia in cesarean-section
下载PDF
导出
摘要 目的:探讨卡前列素氨丁三醇在中央性前置胎盘孕妇剖宫产时的应用时间及疗效.方法:38例中央性前置胎盘孕妇分成2组,研究组26例,年龄(27±s4)a,剖宫产胎儿娩出后予宫体和静脉分别注射缩宫素各20 U,宫缩仍不佳即宫体注射卡前列素氨丁三醇0.25 mg;对照组12例,年龄(31±4)a,剖宫产胎儿娩出后予宫体和静脉注射缩宫素各20 U,宫缩仍不佳再继续应用缩宫素20~50 U,宫缩仍不佳才予宫体注射卡前列素氨丁三醇0.25 mg.结果:研究组术中出血量非常明显低于对照组[(471±240)mLvs(746±339)mL,P<0.01];而2组产妇术后2 h内出血量,差异无显著意义(P>0.05).结论:中央性前置胎盘剖宫产时,应用缩宫素40U后宫缩不佳即应改用卡前列素氨丁三醇,疗效较好. AIM: To explore the application time and effect of carboprost trometamol on bleeding of complete placenta praevia in cesarean-section. METHODS: According to the opportunity of applying carboprost trometamol, 38 parturients were divided into study group (n=26; age (27±s 4) a) and control group (n=12; age (31±4) a). The study group was treated with carboprost tromethamine 0.25 mg if uterine contraction was poor after applying oxytocin 20 U for uterus and intravenous injection of each. The control group was also treated with oxytocin 20-50 U due to poor uterine contraction after applying oxytocin 20 U for each of the uterus and intravenous injection and if uterine contraction was still poor and then followed by applicotion carboprost trometamol 0.25 mg. RESULTS: The blood loss in study group was lower than that in the control group ((471±240) mL vs (746±339) mL,P< 0.01). There was no significant difference of the amount of bleeding within 2 h after cesarean section between the two groups(P> 0.05). CONCLUSION: Carboprost trometamol should be applied if uterine contraction is poor after applying oxytocin 40 U in cesarean-section of complete placenta praevia.
出处 《中国新药与临床杂志》 CAS CSCD 北大核心 2005年第3期223-224,共2页 Chinese Journal of New Drugs and Clinical Remedies
关键词 氨丁三醇 卡前列素 剖官产术 产后出血 胎盘 前置 tromethamine carboprost cesarean section postpartum hemorrhage placenta, praevia
  • 相关文献

参考文献4

  • 1全国孕产妇死亡监测协作组.全国孕产妇死亡监测结果分析[J].中华妇产科杂志,1999,34(11):645-648. 被引量:521
  • 2REYAL F, SIBONY O, OURY JF, et al. Criteria for transfusion in severe postpartum hemorrhage: analysis of practice and risk factors [J]. Eur J Obstet Gynecol Reprod Biol,2004,112 (1) :61-64.
  • 3LAMONT RF, MORGAN DJ, LOGUE M, et al. A prospective randomised trial to compare the efficacy and safety of hemabate and syntometrine for the prevention of primary postpartum haemorrhage [J].Prostaglandins Other Lipid Mediat,2001,66(3) :203-210.
  • 4DILDY GA. Postpartum hemorrhage: new management options[J].Clin Obstet Gynecol,2002 ,45 (2) :330-344.

共引文献520

同被引文献159

引证文献29

二级引证文献485

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部